nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—embryo—Alzheimer's disease	0.0334	0.166	CbGeAlD
Amcinonide—ANXA1—forebrain—Alzheimer's disease	0.0296	0.147	CbGeAlD
Amcinonide—ANXA1—telencephalon—Alzheimer's disease	0.0272	0.135	CbGeAlD
Amcinonide—ANXA1—nervous system—Alzheimer's disease	0.0161	0.0799	CbGeAlD
Amcinonide—ANXA1—central nervous system—Alzheimer's disease	0.0155	0.0769	CbGeAlD
Amcinonide—ANXA1—cerebellum—Alzheimer's disease	0.0151	0.0752	CbGeAlD
Amcinonide—ANXA1—brain—Alzheimer's disease	0.0123	0.0611	CbGeAlD
Amcinonide—NR3C1—embryo—Alzheimer's disease	0.0116	0.0578	CbGeAlD
Amcinonide—NR3C1—forebrain—Alzheimer's disease	0.0103	0.0511	CbGeAlD
Amcinonide—NR3C1—telencephalon—Alzheimer's disease	0.00945	0.047	CbGeAlD
Amcinonide—NR3C1—nervous system—Alzheimer's disease	0.00558	0.0278	CbGeAlD
Amcinonide—NR3C1—central nervous system—Alzheimer's disease	0.00537	0.0267	CbGeAlD
Amcinonide—NR3C1—cerebellum—Alzheimer's disease	0.00525	0.0261	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—NPY—Alzheimer's disease	0.00484	0.00614	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.00475	0.00603	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.00466	0.00591	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Alzheimer's disease	0.00453	0.00575	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—Alzheimer's disease	0.0045	0.00571	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR6—Alzheimer's disease	0.00449	0.0057	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—CREB1—Alzheimer's disease	0.00447	0.00567	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.00442	0.00561	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—LEP—Alzheimer's disease	0.00429	0.00545	CbGpPWpGaD
Amcinonide—NR3C1—brain—Alzheimer's disease	0.00426	0.0212	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—SST—Alzheimer's disease	0.00422	0.00536	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.00417	0.0053	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.00417	0.00529	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—APP—Alzheimer's disease	0.00411	0.00522	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—NOS2—Alzheimer's disease	0.004	0.00508	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—Alzheimer's disease	0.00397	0.00504	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.00385	0.00488	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GAL—Alzheimer's disease	0.00373	0.00473	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.00372	0.00472	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00369	0.00469	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCL2—Alzheimer's disease	0.00361	0.00458	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00352	0.00447	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—APP—Alzheimer's disease	0.0035	0.00445	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.00346	0.00439	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.00336	0.00427	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00336	0.00426	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—PPARGC1A—Alzheimer's disease	0.00327	0.00416	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.00327	0.00415	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.00322	0.00409	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—ESR1—Alzheimer's disease	0.00321	0.00407	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—Alzheimer's disease	0.00321	0.00407	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.00319	0.00406	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00314	0.00399	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00314	0.00399	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00304	0.00386	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Alzheimer's disease	0.00304	0.00386	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PYY—Alzheimer's disease	0.00304	0.00386	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.00303	0.00384	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—MEF2C—Alzheimer's disease	0.00295	0.00375	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—Alzheimer's disease	0.00294	0.00373	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—NPY—Alzheimer's disease	0.00293	0.00372	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—PPARG—Alzheimer's disease	0.00293	0.00371	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—IAPP—Alzheimer's disease	0.00291	0.00369	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.00286	0.00363	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CRH—Alzheimer's disease	0.00283	0.00359	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.00282	0.00358	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—F2—Alzheimer's disease	0.0028	0.00356	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.00279	0.00354	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.00277	0.00351	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PYY—Alzheimer's disease	0.00276	0.0035	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—Alzheimer's disease	0.00274	0.00347	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CASP3—Alzheimer's disease	0.00273	0.00347	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CCR5—Alzheimer's disease	0.00272	0.00345	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—NPS—Alzheimer's disease	0.00268	0.0034	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00267	0.00339	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.00257	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—SST—Alzheimer's disease	0.00255	0.00324	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.00255	0.00324	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.00254	0.00323	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00254	0.00322	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.00253	0.00322	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00251	0.00319	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.00251	0.00319	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.00251	0.00318	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—APP—Alzheimer's disease	0.00249	0.00316	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.00246	0.00313	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00246	0.00313	CbGpPWpGaD
Amcinonide—Triamcinolone—BCHE—Alzheimer's disease	0.00242	0.211	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.00241	0.00306	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—Alzheimer's disease	0.00241	0.00305	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CDK5—Alzheimer's disease	0.00239	0.00304	CbGpPWpGaD
Amcinonide—Fluoxymesterone—ESR1—Alzheimer's disease	0.00235	0.205	CrCbGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.00231	0.00294	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR6—Alzheimer's disease	0.0023	0.00292	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.00228	0.0029	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00225	0.00286	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.00224	0.00285	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.00223	0.00283	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.00217	0.00275	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.00216	0.00275	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.00215	0.00273	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.00215	0.00273	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TGFB1—Alzheimer's disease	0.00213	0.0027	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00212	0.00269	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GAL—Alzheimer's disease	0.00211	0.00267	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.00211	0.00267	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.00209	0.00265	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.00205	0.0026	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.00202	0.00257	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.002	0.00254	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—Alzheimer's disease	0.00199	0.00252	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.00197	0.0025	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.00195	0.00247	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.00194	0.00246	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GAL—Alzheimer's disease	0.00191	0.00243	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.0019	0.00242	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.0019	0.00242	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TTR—Alzheimer's disease	0.00187	0.00237	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.00186	0.00236	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.00185	0.00236	CbGpPWpGaD
Amcinonide—Dexamethasone—NOS2—Alzheimer's disease	0.00185	0.162	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00185	0.00235	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00185	0.00235	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.00177	0.00225	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—Alzheimer's disease	0.00175	0.00222	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.00175	0.00222	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.00173	0.0022	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.00171	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NPY—Alzheimer's disease	0.00165	0.0021	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.00165	0.0021	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCR5—Alzheimer's disease	0.00165	0.00209	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	0.00165	0.00209	CbGpPWpGaD
Amcinonide—Ciclesonide—CYP2D6—Alzheimer's disease	0.00164	0.143	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.00164	0.00209	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PYY—Alzheimer's disease	0.00163	0.00207	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.00161	0.00205	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—Alzheimer's disease	0.0016	0.00203	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CRH—Alzheimer's disease	0.0016	0.00203	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.00158	0.002	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.00157	0.002	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	0.00157	0.002	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	0.00156	0.00198	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NPS—Alzheimer's disease	0.00151	0.00192	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.0015	0.00191	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NPY—Alzheimer's disease	0.0015	0.00191	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LPL—Alzheimer's disease	0.0015	0.0019	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IAPP—Alzheimer's disease	0.00149	0.0019	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	0.00148	0.00188	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CRH—Alzheimer's disease	0.00145	0.00184	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.00145	0.00184	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—SST—Alzheimer's disease	0.00144	0.00183	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.00144	0.00183	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.00144	0.00182	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.00142	0.00181	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDK5—Alzheimer's disease	0.00141	0.00179	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—F2—Alzheimer's disease	0.00141	0.00179	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—APP—Alzheimer's disease	0.00141	0.00179	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00138	0.00175	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NPS—Alzheimer's disease	0.00137	0.00175	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.00137	0.00174	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR6—Alzheimer's disease	0.00136	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.00135	0.00172	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.00133	0.00169	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00133	0.00168	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GAB2—Alzheimer's disease	0.00131	0.00166	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SST—Alzheimer's disease	0.00131	0.00166	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00128	0.00163	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—APP—Alzheimer's disease	0.00128	0.00162	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL2—Alzheimer's disease	0.00126	0.0016	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LEP—Alzheimer's disease	0.00126	0.00159	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PSENEN—Alzheimer's disease	0.00124	0.00157	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00123	0.00156	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APH1A—Alzheimer's disease	0.00122	0.00155	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	0.00121	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.00121	0.00153	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.00119	0.00151	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NCSTN—Alzheimer's disease	0.00119	0.00151	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.00117	0.00148	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LRP1—Alzheimer's disease	0.00116	0.00147	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GFAP—Alzheimer's disease	0.00113	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GAL—Alzheimer's disease	0.00113	0.00143	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—Alzheimer's disease	0.00112	0.0974	CrCbGaD
Amcinonide—NR3C1—Gene Expression—PHF1—Alzheimer's disease	0.00111	0.00141	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	0.00109	0.00139	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	0.00108	0.00137	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—INS—Alzheimer's disease	0.00107	0.00136	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	0.00106	0.00135	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	0.00104	0.00133	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	0.00104	0.00132	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.00103	0.00131	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.00102	0.0013	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.00101	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—A2M—Alzheimer's disease	0.000996	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000992	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000982	0.00125	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000965	0.00122	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000932	0.00118	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.00093	0.00118	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—Alzheimer's disease	0.000915	0.0798	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000911	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000892	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NPY—Alzheimer's disease	0.000888	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IAPP—Alzheimer's disease	0.000882	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CRH—Alzheimer's disease	0.000856	0.00109	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000845	0.00107	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	0.00084	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000827	0.00105	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NPS—Alzheimer's disease	0.000812	0.00103	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000808	0.00103	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—F2—Alzheimer's disease	0.000798	0.00101	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000796	0.00101	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GAB2—Alzheimer's disease	0.000775	0.000983	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SST—Alzheimer's disease	0.000775	0.000983	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000775	0.000983	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000771	0.000979	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	0.000769	0.000976	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000768	0.000975	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APP—Alzheimer's disease	0.000755	0.000958	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	0.00074	0.00094	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—F2—Alzheimer's disease	0.000725	0.00092	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TFAM—Alzheimer's disease	0.000717	0.00091	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000712	0.000904	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000692	0.000878	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.00069	0.000876	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	0.000678	0.00086	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NGFR—Alzheimer's disease	0.000665	0.000844	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CREB1—Alzheimer's disease	0.00066	0.000838	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADAM10—Alzheimer's disease	0.000649	0.000824	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL2—Alzheimer's disease	0.000646	0.00082	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2D6—Alzheimer's disease	0.000634	0.0552	CrCbGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.000631	0.000802	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	0.000625	0.000794	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	0.000622	0.00079	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—S100B—Alzheimer's disease	0.000614	0.000779	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000586	0.000744	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF2—Alzheimer's disease	0.000584	0.000742	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—Alzheimer's disease	0.000581	0.000737	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—Alzheimer's disease	0.000565	0.000717	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LPL—Alzheimer's disease	0.000542	0.000688	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MEF2C—Alzheimer's disease	0.000537	0.000682	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—Alzheimer's disease	0.000532	0.0464	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—PRKCG—Alzheimer's disease	0.000527	0.000669	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NGF—Alzheimer's disease	0.000513	0.000651	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000502	0.000637	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR5—Alzheimer's disease	0.000499	0.000634	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2A—Alzheimer's disease	0.000488	0.00062	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—Alzheimer's disease	0.000469	0.000595	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALM1—Alzheimer's disease	0.000456	0.000579	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—Alzheimer's disease	0.000454	0.000577	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—Alzheimer's disease	0.000454	0.000577	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CAV1—Alzheimer's disease	0.00045	0.000571	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000438	0.000556	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—Alzheimer's disease	0.000434	0.00055	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	0.000432	0.000548	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—F2—Alzheimer's disease	0.000428	0.000544	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000423	0.000537	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000419	0.000532	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000405	0.000514	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000399	0.000507	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GSK3B—Alzheimer's disease	0.000393	0.000499	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CREB1—Alzheimer's disease	0.00039	0.000495	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INS—Alzheimer's disease	0.000388	0.000493	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL2—Alzheimer's disease	0.000382	0.000485	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—Alzheimer's disease	0.000375	0.000476	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—Alzheimer's disease	0.00034	0.000432	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000292	0.00037	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—Alzheimer's disease	0.000289	0.000367	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—Alzheimer's disease	0.000287	0.000364	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK8—Alzheimer's disease	0.000265	0.000337	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—Alzheimer's disease	0.000265	0.000336	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—Alzheimer's disease	0.000245	0.000311	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—Alzheimer's disease	0.000225	0.000286	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—Alzheimer's disease	0.000211	0.000268	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	0.000204	0.000259	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—Alzheimer's disease	0.000192	0.000244	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—Alzheimer's disease	0.000185	0.000235	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—Alzheimer's disease	0.00017	0.000215	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—Alzheimer's disease	0.000156	0.000199	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—Alzheimer's disease	7.6e-05	9.65e-05	CbGpPWpGaD
